| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Verteporfin | FAERS: 12 | US FAERS | |
| 2 | Risperidone | FAERS: 6 | US FAERS | |
| 3 | Insulin | FAERS: 4 | US FAERS | |
| 4 | Triamcinolone Acetonide | FAERS: 3 | US FAERS | |
| 5 | 4-hydroxybutyric acid | FAERS: 2 | US FAERS | |
| 6 | Aripiprazole | FAERS: 2 | US FAERS | |
| 7 | Sildenafil Citrate | FAERS: 2 | US FAERS | |
| 8 | Valacyclovir | FAERS: 2 | US FAERS | |
| 9 | Acyclovir | FAERS: 1 | US FAERS | |
| 10 | Anastrozole | FAERS: 1 | US FAERS | |
| 11 | Dasatinib | FAERS: 1 | US FAERS | |
| 12 | Dexamethasone | FAERS: 1 | US FAERS | |
| 13 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 14 | Doxycycline | FAERS: 1 | US FAERS | |
| 15 | Exenatide | FAERS: 1 | US FAERS | |
| 16 | Fenofibrate | FAERS: 1 | US FAERS | |
| 17 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 18 | Ganfort | FAERS: 1 | US FAERS | |
| 19 | Insulin Glargine | FAERS: 1 | US FAERS | |
| 20 | Levofloxacin | FAERS: 1 | US FAERS | |
| 21 | Mesalamine | FAERS: 1 | US FAERS | |
| 22 | PCI 32765 | FAERS: 1 | US FAERS | |
| 23 | Restasis | FAERS: 1 | US FAERS | |
| 24 | Rosiglitazone | FAERS: 1 | US FAERS | |
| 25 | Simbrinza | FAERS: 1 | US FAERS | |
| 26 | Teriparatide | FAERS: 1 | US FAERS | |
| 27 | Travoprost | FAERS: 1 | US FAERS | |
| 28 | Triamcinolone | FAERS: 1 | US FAERS | |
| 29 | Valacyclovir | FAERS: 1 | US FAERS | |
| 30 | Valproic Acid | FAERS: 1 | US FAERS | |
| 31 | Bimatoprost | OFFSIDES | ||
| 32 | Brimonidine Tartrate | OFFSIDES | ||
| 33 | Buprenorphine | OFFSIDES | ||
| 34 | Colistin | OFFSIDES | ||
| 35 | Gatifloxacin | OFFSIDES | ||
| 36 | Tobramycin | OFFSIDES | ||
| 37 | pegaptanib | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.